Correlation Between BB Biotech and Amundi FTSE

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both BB Biotech and Amundi FTSE at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BB Biotech and Amundi FTSE into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between BB Biotech AG and Amundi FTSE EPRANAREIT, you can compare the effects of market volatilities on BB Biotech and Amundi FTSE and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BB Biotech with a short position of Amundi FTSE. Check out your portfolio center. Please also check ongoing floating volatility patterns of BB Biotech and Amundi FTSE.

Diversification Opportunities for BB Biotech and Amundi FTSE

-0.25
  Correlation Coefficient

Very good diversification

The 3 months correlation between BION and Amundi is -0.25. Overlapping area represents the amount of risk that can be diversified away by holding BB Biotech AG and Amundi FTSE EPRANAREIT in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Amundi FTSE EPRANAREIT and BB Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BB Biotech AG are associated (or correlated) with Amundi FTSE. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Amundi FTSE EPRANAREIT has no effect on the direction of BB Biotech i.e., BB Biotech and Amundi FTSE go up and down completely randomly.

Pair Corralation between BB Biotech and Amundi FTSE

Assuming the 90 days trading horizon BB Biotech AG is expected to under-perform the Amundi FTSE. In addition to that, BB Biotech is 1.13 times more volatile than Amundi FTSE EPRANAREIT. It trades about -0.2 of its total potential returns per unit of risk. Amundi FTSE EPRANAREIT is currently generating about -0.17 per unit of volatility. If you would invest  4,631  in Amundi FTSE EPRANAREIT on September 13, 2024 and sell it today you would lose (177.00) from holding Amundi FTSE EPRANAREIT or give up 3.82% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

BB Biotech AG  vs.  Amundi FTSE EPRANAREIT

 Performance 
       Timeline  
BB Biotech AG 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days BB Biotech AG has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, BB Biotech is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.
Amundi FTSE EPRANAREIT 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Amundi FTSE EPRANAREIT has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Etf's basic indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the exchange-traded fund private investors.

BB Biotech and Amundi FTSE Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with BB Biotech and Amundi FTSE

The main advantage of trading using opposite BB Biotech and Amundi FTSE positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BB Biotech position performs unexpectedly, Amundi FTSE can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amundi FTSE will offset losses from the drop in Amundi FTSE's long position.
The idea behind BB Biotech AG and Amundi FTSE EPRANAREIT pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.

Other Complementary Tools

Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Money Managers
Screen money managers from public funds and ETFs managed around the world
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Fundamental Analysis
View fundamental data based on most recent published financial statements
Content Syndication
Quickly integrate customizable finance content to your own investment portal